Products for Research Use Only
RegisterLogin

Theralizumab

CAT: 0931-T77093-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T77093-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
906068-56-2
Target
Others, Immunology/Inflammation related
Related Pathways
Others, Immunology/Inflammation
Purity
0.9946
Bioactivity
Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
M36814-01Theralizumab
GTR18337671-01Theralizumab Antibody
HY422026-01Research Grade Theralizumab
047911CD28 (Theralizumab) discontinued
E55B0899Theralizumab (Reference antibody)
F1386-5Anti-CD28 Antibody (Theralizumab)
ICH5023-50mgTheralizumab Biosimilar - Research Grade
GTR18697199-01Theralizumab Human Monoclonal Antibody
A135634Theralizumab Biosimilar (Monoclonal, IgG4)
GTR18315636CD28 Reference Antibody (Theralizumab)

Popular Products